MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells.

about

MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells.

Item

http://www.wikidata.org/entity/Q52720005

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells.

@en

MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells.

@nl

type

Item

label

MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells.

@en

MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells.

@nl

prefLabel

MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells.

@en

MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells.

@nl

P1476

MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells.

@en

P2093

Bingyue Zhang

http://www.w3.org/2001/XMLSchema#string

Fubo Zhong

http://www.w3.org/2001/XMLSchema#string

Jie Zhang

http://www.w3.org/2001/XMLSchema#string

Shubin Wang

http://www.w3.org/2001/XMLSchema#string

Yajing Liu

http://www.w3.org/2001/XMLSchema#string

Yuxia Li

http://www.w3.org/2001/XMLSchema#string

Zhengyu Fang

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNAs: target recognition and regulatory functions

Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer.

Cutaneous Melanoma in Asians

A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus

miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2.

Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.

Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.

SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma.

microRNA-199a is able to reverse cisplatin resistance in human ovarian cancer cells through the inhibition of mammalian target of rapamycin.

Crosstalk between the IGF-1R/AKT/mTORC1 pathway and the tumor suppressors p53 and p27 determines cisplatin sensitivity and limits the effectiveness of an IGF-1R pathway inhibitor.

P2888

s12885-018-4233-9

P304

404

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-018-4233-9

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103149209

http://www.w3.org/2001/XMLSchema#string

P698

29642855

http://www.w3.org/2001/XMLSchema#string

P932

5896053

http://www.w3.org/2001/XMLSchema#string